Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases.

Objectives: To determine whether tumour enhancement on preoperative delayed-phase gadoxetate-enhanced MRI can predict long-term survival in patients with colorectal liver metastases (CRCLM) post-hepatectomy.Materials and Methods: Sixty-five patients who received a preoperative gadoxetate-enhanced MR...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 29; no. 2; pp. 1032 - 1039
Autores principales: Cheung, Helen M. C., Karanicolas, Paul J., Coburn, Natalie, Seth, Vikrum, Law, Calvin, Milot, Laurent
Formato: Journal Article
Publicado: Springer Nature Feb2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=133695321&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 133695321
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: Feb2019
      vid: 29
      iid: 2
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        133695321
        133695321
        NLM29992388
        10.1007/s00330-018-5618-5
        NLM29992388
        133695321
      ppf: 1032
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases.
      aug:
        au:
          Cheung, Helen M. C.
          Karanicolas, Paul J.
          Coburn, Natalie
          Seth, Vikrum
          Law, Calvin
          Milot, Laurent
        affil: Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Rm AB 202, M4N 3M5, Toronto, ON, Canada
      sug:
        subj:
          Contrast Media Pharmacodynamics
          Magnetic Resonance Imaging Methods
          Colorectal Neoplasms Pathology
          Liver Neoplasms
          Middle Age
          Ontario
          Adult
          Liver Neoplasms Mortality
          Female
          Aged
          Retrospective Design
          Time Factors
          Colorectal Neoplasms Mortality
          Male
          Liver Neoplasms Diagnosis
          Scales
          Middle Aged: 45-64 years
          Adult: 19-44 years
          Aged: 65+ years
          Female
          Male
      ab: Objectives: To determine whether tumour enhancement on preoperative delayed-phase gadoxetate-enhanced MRI can predict long-term survival in patients with colorectal liver metastases (CRCLM) post-hepatectomy.Materials and Methods: Sixty-five patients who received a preoperative gadoxetate-enhanced MRI prior to liver resection for CRCLM from January 1, 2010, to December 31, 2012, were included in this retrospective study. Target tumour enhancement (TuEn) was calculated as the mean percentage increase in SNR from precontrast to 10-min or 20-min delayed phase for up to two target lesions. Per-patient TuEn was stratified into weak and strong enhancement based on the cut-off determined by the Youden Index for 3-year survival. Kaplan-Meier and Cox regression analyses were used to determine whether tumour enhancement could predict overall survival independent of potential confounders (clinical risk score).Results: The proportion surviving at 3 years was 85.1% in patients with strong TuEn at 10 min vs. 56.5% in those with weak TuEn at 10 min (p = 0.001). The proportion surviving at 3 years was 79.4% in patients with strong TuEn at 20 min vs. 58.7% in those with weak TuEn at 20 min (p = 0.011). After adjusting for potential confounders, the hazard ratio of death was 0.24 (p = 0.009) in patients who had weak TuEn at 10 min and 0.32 (p = 0.018) in patients who had weak TuEn at 20 min.Conclusions: Strong delayed tumour enhancement seen on gadoxetate-enhanced MRI is associated with overall survival in patients with CRCLM post-hepatectomy and may be useful for preoperative risk stratification.Key Points: • Delayed tumour enhancement of colorectal liver metastases on gadoxetate-enhanced MRI is associated with survival post-hepatectomy • Delayed tumour enhancement of colorectal liver metastases on gadoxetate-enhanced MRI can be measured at both 10 min and 20 min post-contrast injection.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N